A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis

Annals of Neurology

Volumn 71, Issue 2, 2012, Pages 186-194

  Shields, Shannon D ^a,b   Cheng, Xiaoyang ^a,b   Gasser, Andreas ^a,b,f   Saab, Carl Y ^c,d   Tyrrell, Lynda ^a,b   Eastman, Emmanuella M ^a,b,e   Iwata, Masashi ^c,d   Zwinger, Pamela J ^a,b   Black, Joel A ^a,b   Dib Hajj, Sulayman D ^a,b   Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) N (3,5 DIMETHOXYPHENYL) FURAN 2 CARBOXAMIDE; A 803467; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DYSFUNCTION; CEREBELLUM; CEREBELLUM DISEASE; CHANNELOPATHY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; ECTOPIC TISSUE; ELECTROPHYSIOLOGY; ENCEPHALOMYELITIS; LOCOMOTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PURKINJE CELL; UPREGULATION;

ANILINE COMPOUNDS; ANIMALS; CEREBELLAR DISEASES; CEREBELLUM; CHANNELOPATHIES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FURANS; MICE; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; PURKINJE CELLS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; UP-REGULATION;

EID: 84857606247     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22665     Document Type: Article

References (33)

1. Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918-934.
2. Swingler RJ, Compston DA,. The morbidity of multiple sclerosis. Q J Med 1992; 83: 325-337.
3. Thompson AJ, Toosy AT, Ciccarelli O,. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 2010; 9: 1182-1199.
4. Weinshenker BG, Rice GP, Noseworthy JH, et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114 (pt 2): 1045-1056.
5. McAlpine D, Matthews WB,. McAlpine's multiple sclerosis. 2nd ed. Edinburgh, UK and New York, NY: Churchill Livingstone, 1991.
6. Black JA, Fjell J, Dib-Hajj S, et al. Abnormal expression of SNS/PN3 sodium channel in cerebellar Purkinje cells following loss of myelin in the taiep rat. Neuroreport 1999; 10: 913-918. (Pubitemid 29317964)
7. Black JA, Dib-Hajj S, Baker D, et al. Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci U S A 2000; 97: 11598-11602.
8. Fazio F, Notartomaso S, Aronica E, et al. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis. Neuropharmacology 2008; 55: 491-499.
9. Smeyne RJ, Chu T, Lewin A, et al. Local control of granule cell generation by cerebellar Purkinje cells. Mol Cell Neurosci 1995; 6: 230-251.
10. Stirling LC, Forlani G, Baker MD, et al. Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice. Pain 2005; 113: 27-36. (Pubitemid 40038443)
11. Madisen L, Zwingman TA, Sunkin SM, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 2010; 13: 133-140.
12. Cavanaugh DJ, Lee H, Lo L, et al. Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc Natl Acad Sci U S A 2009; 106: 9075-9080.
13. Crawley JN,. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. New York, NY: Wiley-Liss, 2000.
14. Saab CY, Craner MJ, Kataoka Y, Waxman SG,. Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis. Exp Brain Res 2004; 158: 1-8. (Pubitemid 39208518)
15. Gasser A, Cheng X, Gilmore ES, et al. Two Nedd4-binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK. J Biol Chem 2010; 285: 26149-26161.
16. Hudmon A, Choi JS, Tyrrell L, et al. Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 2008; 28: 3190-3201. (Pubitemid 351442277)
17. Choi JS, Dib-Hajj SD, Waxman SG,. Differential slow inactivation and use-dependent inhibition of Nav1.8 channels contribute to distinct firing properties in IB4+ and IB4- DRG neurons. J Neurophysiol 2007; 97: 1258-1265. (Pubitemid 46239503)
18. Lo AC, Saab CY, Black JA, Waxman SG,. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 2003; 90: 3566-3571. (Pubitemid 37430046)
19. Haley TJ, McCormick WG,. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957; 12: 12-15.
20. Oberdick J, Smeyne RJ, Mann JR, et al. A promoter that drives transgene expression in cerebellar Purkinje and retinal bipolar neurons. Science 1990; 248: 223-226.
21. Akopian AN, Sivilotti L, Wood JN,. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996; 379: 257-262.
22. Renganathan M, Gelderblom M, Black JA, Waxman SG,. Expression of Nav1.8 sodium channels perturbs the firing patterns of cerebellar Purkinje cells. Brain Res 2003; 959: 235-242. (Pubitemid 35472185)
23. Granit R, Phillips CG,. Excitatory and inhibitory processes acting upon individual Purkinje cells of the cerebellum in cats. J Physiol 1956; 133: 520-547.
24. Armstrong DM, Rawson JA,. Activity patterns of cerebellar cortical neurones and climbing fibre afferents in the awake cat. J Physiol 1979; 289: 425-448. (Pubitemid 9156874)
25. Amor S, Smith PA, Hart B, Baker D,. Biozzi mice: of mice and human neurological diseases. J Neuroimmunol 2005; 165: 1-10. (Pubitemid 40984618)
26. Hermiston ML, Zikherman J, Zhu JW,. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol Rev 2009; 228: 288-311.
27. Guillemin GJ, Brew BJ,. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004; 75: 388-397. (Pubitemid 38316367)
28. Jarvis MF, Honore P, Shieh CC, et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A 2007; 104: 8520-8525. (Pubitemid 47175520)
29. McGaraughty S, Chu KL, Scanio MJ, et al. A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2- carboxamide], attenuates spinal neuronal activity in neuropathic rats. J Pharmacol Exp Ther 2008; 324: 1204-1211. (Pubitemid 351397859)
30. Moldovan M, Alvarez S, Pinchenko V, et al. Nav1.8 channelopathy in mutant mice deficient for myelin protein zero is detrimental to motor axons. Brain 2011; 134: 585-601.
31. Andermann F, Cosgrove JB, Lloyd-Smith D, Walters AM,. Paroxysmal dysarthria and ataxia in multiple sclerosis; a report of 2 unusual cases. Neurology 1959; 9: 211-215.
32. Espir ML, Watkins SM, Smith HV,. Paroxysmal dysarthria and other transient neurological disturbances in disseminated sclerosis. J Neurol Neurosurg Psychiatry 1966; 29: 323-330.
33. Ptacek LJ, Fu YH,. Channelopathies: episodic disorders of the nervous system. Epilepsia 2001; 42 (suppl 5): 35-43. (Pubitemid 32947925)